Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction

Journal of Surgical Oncology

Volumn 107, Issue 6, 2013, Pages 585-590

  Klaver, Yvonne L B ^a   Chua, Terence C ^b,c   Verwaal, Victor J ^d   De Hingh, Ignace H J T ^a   Morris, David L ^b,c  

^a CATHARINA HOSPITAL   (Netherlands)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

colorectal cancer; cytoreductive surgery; metastasis; peritoneal carcinomatosis

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; PERITONEUM CANCER; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; REOPERATION;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PERITONEUM; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876409945     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23303     Document Type: Conference Paper

References (24)

1. Jayne DG, Fook S, Loi C, et al.: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550.
2. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-363.
3. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743.
4. Bijelic L, Yan TD, Sugarbaker PH:, Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 2008; 98: 295-299.
5. Portilla AG, Sugarbaker PH, Chang D:, Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features. World J Surg 1999; 23: 23-29.
6. Verwaal VJ, Boot H, Aleman BM, et al.: Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome. Ann Surg Oncol 2004; 11: 375-379.
7. Bijelic L, Yan TD, Sugarbaker PH:, Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007; 14: 2281-2288.
8. Saxena A, Yan TD, Morris DL:, Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures. Eur J Surg Oncol 2010; 36: 309-314.
9. Jacquet P, Sugarbaker PH:, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359-374.
10. Sugarbaker PH:, Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
11. Kianmanesh R, Scaringi S, Sabate JM, et al.: Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245: 597-603.
12. Brouquet A, Goere D, Lefevre JH, et al.: The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: Postoperative course and long-term outcome. Ann Surg Oncol 2009; 16: 2744-2751.
13. Golse N, Bakrin N, Passot G, et al.: Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long-term results. J Surg Oncol 2012; 106: 197-203.
14. Elias D, Benizri E, Di Pietrantonio D, et al.: Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 2007; 14: 509-514.
15. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004; 22: 3284-3292.
16. Gomez PA, Barrios P, Rufian S, et al.: Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 2006; 32: 628-631.
17. Elias D, Blot F, El Otmany, A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76.
18. Klaver YL, Hendriks T, Lomme RM, et al.: Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: An experimental study. Ann Surg Oncol 2012; 19: 475-482.
19. Glockzin G, von Breitenbuch P, Schlitt HJ, et al.: Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: A matched-pair analysis. J Surg Oncol 2012 [Epub ahead of print].
20. Hurwitz HI, Fehrenbacher L, Hainsworth JD, et al.: Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer. J Clin Oncol 2005; 23: 3502-3508.
21. Kabbinavar FF, Schulz J, McCleod M, et al.: Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial. J Clin Oncol 2005; 23: 3697-3705.
22. Tol J, Koopman M, Cats A, et al.: Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009; 360: 563-572.
23. Lemmens VE, Klaver YL, Verwaal VJ, et al.: Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study. Int J Cancer 2011; 128: 2717-2725.
24. Klaver YL, Lemmens VE, Creemers GJ, et al.: Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 2011; 22: 2250-2256.